These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 2080018

  • 21. Post-translational processing of the neurotensin/neuromedin N precursor in the central nervous system of the rat--I. Biochemical characterization of maturation products.
    de Nadai F, Rovère C, Bidard JN, Cuber JC, Beaudet A, Kitabgi P.
    Neuroscience; 1994 May; 60(1):159-66. PubMed ID: 8052409
    [Abstract] [Full Text] [Related]

  • 22. Differential catabolic fate of neuromedin N and neurotensin in the canine intestinal mucosa.
    Barelli H, Mao YK, Vincent B, Daniel EE, Vincent JP, Checler F.
    Peptides; 1993 May; 14(3):457-63. PubMed ID: 8332546
    [Abstract] [Full Text] [Related]

  • 23. Immunohistochemical evidence for the involvement of protein convertases 5A and 2 in the processing of pro-neurotensin in rat brain.
    Villeneuve P, Lafortune L, Seidah NG, Kitabgi P, Beaudet A.
    J Comp Neurol; 2000 Aug 28; 424(3):461-75. PubMed ID: 10906713
    [Abstract] [Full Text] [Related]

  • 24. Pro-neurotensin/neuromedin N expression and processing in human colon cancer cell lines.
    Rovère C, Barbero P, Maoret JJ, Laburthe M, Kitabgi P.
    Biochem Biophys Res Commun; 1998 May 08; 246(1):155-9. PubMed ID: 9600085
    [Abstract] [Full Text] [Related]

  • 25. Neurotensin release by rat hypothalamic fragments in vitro.
    Maeda K, Frohman LA.
    Brain Res; 1981 Apr 06; 210(1-2):261-9. PubMed ID: 6261874
    [Abstract] [Full Text] [Related]

  • 26. Neuromedin N mimics the actions of neurotensin in the ventral tegmental area but not in the nucleus accumbens.
    Kalivas PW, Richardson-Carlson R, Duffy P.
    J Pharmacol Exp Ther; 1986 Sep 06; 238(3):1126-31. PubMed ID: 3755755
    [Abstract] [Full Text] [Related]

  • 27. Isolation and primary structure of an amphibian neurotensin.
    Shaw C, McKay DM, Halton DW, Thim L, Buchanan KD.
    Regul Pept; 1992 Mar 05; 38(1):23-31. PubMed ID: 1574601
    [Abstract] [Full Text] [Related]

  • 28. Agonist properties of a stable hexapeptide analog of neurotensin, N alpha MeArg-Lys-Pro-Trp-tLeu-Leu (NT1).
    Akunne HC, Demattos SB, Whetzel SZ, Wustrow DJ, Davis DM, Wise LD, Cody WL, Pugsley TA, Heffner TG.
    Biochem Pharmacol; 1995 Apr 18; 49(8):1147-54. PubMed ID: 7748196
    [Abstract] [Full Text] [Related]

  • 29. The electrophysiological actions of neurotensin in the central nervous system.
    Stowe ZN, Nemeroff CB.
    Life Sci; 1991 Apr 18; 49(14):987-1002. PubMed ID: 1890928
    [Abstract] [Full Text] [Related]

  • 30. Regulation of neurotensin secretion in mammalian C cell lines: potassium and norepinephrine affect the rapid release of the peptide.
    Zeytinoğlu FN, Brazeau P, Culkin MK.
    Regul Pept; 1983 May 18; 6(2):155-62. PubMed ID: 6878754
    [Abstract] [Full Text] [Related]

  • 31. The use of radioimmunoassay to compare the tissue and subcellular distributions of neurotensin and neuromedin N in the cat.
    Carraway RE, Mitra SP.
    Endocrinology; 1987 May 18; 120(5):2092-100. PubMed ID: 3569126
    [Abstract] [Full Text] [Related]

  • 32. Production of recombinant large proneurotensin/neuromedin N-derived peptides and characterization of their binding and biological activity.
    Friry C, Feliciangeli S, Richard F, Kitabgi P, Rovere C.
    Biochem Biophys Res Commun; 2002 Feb 01; 290(4):1161-8. PubMed ID: 11811984
    [Abstract] [Full Text] [Related]

  • 33. Rapid degradation of neurotensin by stimulated rat mast cells.
    Cochrane DE, Carraway RE, Boucher W, Feldberg RS.
    Peptides; 1991 Feb 01; 12(6):1187-94. PubMed ID: 1726119
    [Abstract] [Full Text] [Related]

  • 34. Blood-brain barrier transport kinetics of the neuromedin peptides NMU, NMN, NMB and NT.
    Gevaert B, Wynendaele E, Stalmans S, Bracke N, D'Hondt M, Smolders I, van Eeckhaut A, De Spiegeleer B.
    Neuropharmacology; 2016 Aug 01; 107():460-470. PubMed ID: 27040796
    [Abstract] [Full Text] [Related]

  • 35. Blockade of neurotensin binding in the rat hypothalamus and of the central action of neurotensin on the hypothalamic-pituitary-adrenal axis with non-peptide receptor antagonists.
    Nicot A, Bérod A, Gully D, Rowe W, Quirion R, de Kloet ER, Rostène W.
    Neuroendocrinology; 1994 Jun 01; 59(6):572-8. PubMed ID: 8084381
    [Abstract] [Full Text] [Related]

  • 36. Pharmacological role and degradation processes of neuromedin N in the gastrointestinal tract: an in vitro and in vivo study.
    Barelli H, Woskowska Z, Cipris S, Fox-Threlkeld JE, Daniel EE, Vincent JP, Checler F.
    J Pharmacol Exp Ther; 1995 Dec 01; 275(3):1300-7. PubMed ID: 8531096
    [Abstract] [Full Text] [Related]

  • 37. The regional distribution and chromatographic characterisation of neurotensin-like immunoreactivity in the rat central nervous system.
    Emson PC, Goedert M, Horsfield P, Rioux F, St Pierre S.
    J Neurochem; 1982 Apr 01; 38(4):992-9. PubMed ID: 7062044
    [Abstract] [Full Text] [Related]

  • 38. Opiate-mediated inhibition of the release of cholecystokinin and substance P, but not neurotensin from cat hypothalamic slices.
    Micevych PE, Yaksh TL, Go VL.
    Brain Res; 1982 Nov 04; 250(2):283-9. PubMed ID: 6184121
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.